Reappraisal of digitalis. X. Treatment of digitalis toxicity.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000009:adverse effects*; D004492:Edetic Acid / Q000627:therapeutic use; D004558:Electric Stimulation; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007008:Hypokalemia / Q000150:complications; D010672:Phenytoin / Q000627:therapeutic use; D011189:Potassium Chloride / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced*
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D010672:Phenytoin; D011189:Potassium Chloride; D004492:Edetic Acid; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide